CNO
Overvalued by 0.3% based on the discounted cash flow analysis.
Market cap | $2.96 Billion |
---|---|
Enterprise Value | $7.11 Billion |
Dividend Yield | $0.5949 (2.19%) |
Earnings per Share | $2.44 |
Beta | 1.14 |
Outstanding Shares | 108,991,851 |
Avg 30 Day Volume | 782,116 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | 10.71 |
---|---|
PEG | -65.44 |
Price to Sales | 0.72 |
Price to Book Ratio | 1.37 |
Enterprise Value to Revenue | 1.71 |
Enterprise Value to EBIT | 19.93 |
Enterprise Value to Net Income | 25 |
Total Debt to Enterprise | 0.58 |
Debt to Equity | 1.87 |
No data
No data